Asthma drug delivery study halted before starting
NCT ID NCT04973345
Summary
This study aimed to understand how an asthma drug called terbutaline sulfate works in the body when given through an IV versus an injection under the skin. The goal was to find the best IV dose for future research by measuring drug levels and lung function in adults with asthma. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of Vermont
Burlington, Vermont, 05401, United States
Conditions
Explore the condition pages connected to this study.